Improving the control of multidrug-resistant tuberculosis through targeted screening and use of novel anti-tuberculosis drugs

通过针对性筛选和使用新型抗结核药物提高耐多药结核病的控制

基本信息

  • 批准号:
    9109823
  • 负责人:
  • 金额:
    $ 13.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-15 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This proposal presents a four-year research career development award for Dr. Reza Yaesoubi, an Assistant Professor in the Department of Health Policy and Management at the Yale School of Public Health (YSPH). His proposal aims to address important policy questions to control the ongoing spread of multidrug-resistant tuberculosis (MDR-TB) strains, which are resistant to essential antibiotics included in the first-line TB treatment regimen. While global efforts to scale up the diagnosis and treatment of MDR-TB and confront the growing problem of drug resistance have been slow moving, the recent introduction of new tools to control the threat of MDR-TB offer promise to accelerate the response. These new tools include rapid diagnostic tests for drug resistance and the novel anti-TB drugs. This proposal describes a rigorous, model-based investigation to identify strategies that can maximize the beneficial impact of these novel tools for TB and MDR-TB control. To study the overall impact of different control policies on MDR-TB spread, the candidate will develop detailed mathematical and simulation models of TB epidemics and calibrate them using data from two high MDR-TB prevalence countries, Peru and The Republic of Moldova (Aim 1). The candidate will then use these models to i) identify cost-effective, adaptive policies which use updated epidemiological information to guide targeted screening for TB and MDR-TB (Aim 2); and ii) identify drug-introduction policies that maximize the societal benefits of novel anti-T drugs and regimens while minimizing the probability of the emergence of antibiotic resistance (Aim 3). The proposed work will be conducted under the co-mentorship of Dr. Ted Cohen, MD, MPH, DrPH, Associate Professor of Epidemiology of Microbial Diseases at YSPH, and Dr. A. David Paltiel, PhD, MBA, Professor of Public Health, and Health Policy and Management at YSPH, and will be done in collaboration with the Center for Interdisciplinary Research on AIDS, the Center for Infectious Disease Modeling at YSPH, and the Center for Communicable Disease Dynamics at the Harvard School of Public Health (HSPH).The candidate will also be advised by Dr. Marc Lipsitch, DPhill, Professor of Epidemiology at HSPH and Dr. Joshua Salomon, PhD, Professor of Global Health at HSPH. Dr. Yaesoubi's training goals are (1) to develop a solid understanding of the dynamics of infectious diseases and the biological mechanisms governing the emergence of resistant bacteria, in particular MDR-TB, (2) to become an expert in methods for modeling complex multi-agent systems and optimizing the overall performance of these systems through the efficient allocation of available resources, and (3) to improve his mentoring, management, and collaboration skills that are essential for his successful transition to independence. The candidate's long-term goal is to become an independent scientist developing and applying decision science techniques to improve policies for the management and eradication of infectious diseases.
 描述(由应用程序提供):该提案为耶鲁公共卫生学院(YSPH)的卫生政策与管理部助理教授Reza Yaesoubi博士颁​​发了为期四年的研究职业发展奖。他的建议旨在解决重要的政策问题,以控制多种抗性结核病(MDR-TB)菌株的持续扩散,这些菌株对第一线结核病治疗方案中包含的基本抗生素具有抗药性。尽管全球扩大MDR-TB的诊断和治疗以及面对耐药性越来越大的问题的努力一直缓慢移动,但最近引入了控制MDR-TB威胁的新工具提供了有望加速反应的承诺。这些新工具包括耐药性和新型抗TB药物的快速诊断测试。该提案描述了一项严格的,基于模型的投资,以确定可以最大程度地利用这些新型工具对结核病和MDR-TB控制的有益影响的策略。为了研究不同控制策略对MDR-TB扩散的总体影响,候选人将开发TB流行病的详细数学和仿真模型,并使用来自两个高MDR-TB流行国家和摩尔多瓦共和国的数据来校准它们(AIM 1)。然后,候选人将使用这些模型i)确定使用更新的流行病学信息来指导TB和MDR-TB的目标筛查(AIM 2);和ii)确定最大化新型抗T药物和方案的社会益处的药物引入政策,同时最大程度地减少出现抗生素耐药性的可能性(AIM 3)。 The proposed work will be conducted under the co-mentorship of Dr. Ted Cohen, MD, MPH, DrPH, Associate Professor of Epidemiology of Microbial Diseases at YSPH, and Dr. A. David Paltiel, PhD, MBA, Professor of Public Health, and Health Policy and Management at YSPH, and will be done in collaboration with the Center for Interdisciplinary Research on AIDS, the Center for Infectious Disease Modeling at YSPH和哈佛公共卫生学院(HSPH)的传染性疾病动态中心。候选人也将由HSPH的Dphill,Dphill,Dphill博士和HSPH全球健康教授Joshua Salomon博士,HSPH博士提供建议。 Yaesoubi博士的培训目标是(1),以深入了解感染性疾病的动态以及管理抗性细菌出现的生物学机制,尤其是MDR-TB的出现,(2)成为建模复杂的多项式系统的方法的专家,并通过有效地分配了这些系统,以有效地分配了这些系统,以提高这些系统的整体性能,以改善他的精神和(3),并(3)能够改善他和(3),并(3)能够改善他和(3),并(3)能够改善他的精神和(3),并(3)能够改善他的精神和(3)。过渡到独立。候选人的长期目标是成为一名独立的科学家发展,并运用决策科学技术,以改善管理和消除传染病的政策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Reza YAESOUBI其他文献

Reza YAESOUBI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Reza YAESOUBI', 18)}}的其他基金

A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemic
一个决策工具,用于告知在 COVID-19 大流行期间如何最佳使用非药物干预措施
  • 批准号:
    10738630
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
加强监测系统以减缓抗菌药物耐药性淋病在美国的传播
  • 批准号:
    10623254
  • 财政年份:
    2020
  • 资助金额:
    $ 13.1万
  • 项目类别:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
加强监测系统以减缓抗菌药物耐药性淋病在美国的传播
  • 批准号:
    10031094
  • 财政年份:
    2020
  • 资助金额:
    $ 13.1万
  • 项目类别:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
加强监测系统以减缓抗菌药物耐药性淋病在美国的传播
  • 批准号:
    10200650
  • 财政年份:
    2020
  • 资助金额:
    $ 13.1万
  • 项目类别:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
加强监测系统以减缓抗菌药物耐药性淋病在美国的传播
  • 批准号:
    10415148
  • 财政年份:
    2020
  • 资助金额:
    $ 13.1万
  • 项目类别:
Improving the control of multidrug-resistant tuberculosis through targeted screening and use of novel anti-tuberculosis drugs
通过针对性筛选和使用新型抗结核药物提高耐多药结核病的控制
  • 批准号:
    9261472
  • 财政年份:
    2016
  • 资助金额:
    $ 13.1万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686546
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
Applying Deep Learning for Predicting Retention in PrEP Care and Effective PrEP Use among Key Populations at Risk for HIV in Thailand
应用深度学习预测泰国主要艾滋病毒高危人群中 PrEP 护理的保留情况以及 PrEP 的有效使用
  • 批准号:
    10619943
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
  • 批准号:
    10762645
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
Long-acting multi prevention implant for 2-year contraception and HIV PrEP
用于 2 年避孕和 HIV PrEP 的长效多重预防植入物
  • 批准号:
    10619811
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs
减少注射毒品的塔吉克移民的跨部门耻辱
  • 批准号:
    10755435
  • 财政年份:
    2023
  • 资助金额:
    $ 13.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了